Gossamer Bio Inc. (NASDAQ: GOSS) reported Q2 EPS of ($0.08), $0.04 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $9.24 million versus the consensus estimate of $4.28 million.

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.